Groundbreaking results in type 1 diabetes research

Story by Christiane Manow-Le Ruyet | Nov 29, 2018 | Tags: Helmholz Zentrum, muenchen, stemm cells

MUNICH, 29th November 2018 – German scientists have taken a major step forward in research into type 1 diabetes. They have identified the signals responsible for the development of immature pancreatic cells. This could pave the way for the modification of stem cells into insulin-producing pancreatic cells.

The study was led by Prof. Dr. Henrik Semb. The aim is to find new approaches for cell replacement therapy in type 1 diabetes. He recently joined the Helmholz Zentrum in Munich. There he is responsible for the Institute for Translational Stem Cell Research. He is also Professor at the Novo Nordisk Foundation Center form Stem Cell Biology (DanStem) at the University of Copenhagen.

Continue here –> InnovationOrigins.com

You can already read another article on this here  –>  Diabetes.co.uk